EMG
ANIK icon

Ellington Management Group’s Anika Therapeutics ANIK Stock Holding History

Ellington Management Group’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-7,907
Closed -$239K – 574
2019
Q1 		$239K Buy
+7,907
New +$271K 0.05% 426
2016
Q1 		– Sell
-11,049
Closed -$422K – 492
2015
Q4 		$422K Sell
11,049
-7,599
-41% -$291K 0.19% 178
2015
Q3 		$594K Buy
+18,648
New +$650K 0.17% 180
2015
Q2 		– Sell
-4,900
Closed -$202K – 676
2015
Q1 		$202K Buy
+4,900
New +$198K 0.04% 596
2014
Q4 		– Sell
-9,500
Closed -$348K – 554
2014
Q3 		$348K Buy
9,500
+4,300
+83% +$186K 0.24% 125
2014
Q2 		$241K Buy
+5,200
New +$231K 0.11% 295
2014
Q1 		– Sell
-12,500
Closed -$477K – 600
2013
Q4 		$477K Buy
+12,500
New +$386K 0.17% 190

Other funds holding ANIK

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return